Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Windgap Medical is a medical device company focused on developing next-generation autoinjectors for the delivery of complex and heat-sensitive drugs. The company's flagship technology, the ANDI platform, is designed to simplify the administration of medications that require reconstitution or are otherwise difficult to deliver in emergency settings. Their lead program is a compact, easy-to-use epinephrine autoinjector intended to treat anaphylaxis with improved portability and shelf-life compared to traditional devices. Beyond epinephrine, Windgap is leveraging its platform to develop delivery solutions for indications such as cyanide poisoning and various chronic conditions requiring large-volume or high-viscosity injections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Windpack.